Preparation, characterization, and in vitro evaluation of ezetimibe binary solid dispersions with poloxamer 407 and PVP K30

Journal of Pharmaceutical Innovation

Volumn 6, Issue 2, 2011, Pages 107-114

  Parmar, Komal R ^a   Shah, Sunny R ^a   Sheth, Navin R ^a  

^a SAURASHTRA UNIVERSITY   (India)

Author keywords

Characterization; Dissolution; Ezetimibe; L 127; PVP K30

Indexed keywords

EZETIMIBE; POLOXAMER; POVIDONE;

ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; SOLID STATE; X RAY POWDER DIFFRACTION;

EID: 79960455633     PISSN: 18725120     EISSN: 19398042     Source Type: Journal    
DOI: 10.1007/s12247-011-9104-8     Document Type: Article

References (27)

1. CA Lipinski F Lombardo BW Dominy PJ Feeney 2001 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 46 3 26 11259830 10.1016/S0169-409X(00)00129-0 1:CAS:528:DC%2BD3MXitVOhs7o%3D (Pubitemid 33653411)
2. A Fahr X Liu 2007 Drug delivery strategies for poorly water-soluble drugs Expert Opin Drug Deliv 4 4 403 416 17683253 10.1517/17425247.4.4.403 1:CAS:528:DC%2BD2sXos1ansL4%3D (Pubitemid 47249138)
3. D Horter JB Dressman 2001 Influence of physicochemical properties on dissolution of drug in the gastrointestinal tract Adv Drug Deliv Rev 46 75 87 11259834 10.1016/S0169-409X(00)00130-7 1:CAS:528:DC%2BD3MXitVOhs7Y%3D
4. ATM Serajuddin 1999 Solid dispersions of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs J Pharm Sci 88 10 1058 1066 10514356 10.1021/js980403l 1:CAS:528:DyaK1MXltl2jtbk%3D (Pubitemid 29480600)
5. C Leuner J Dressman 2000 Improving drug solubility for oral delivery using solid dispersions Eur J Pharm Biopharm 50 47 60 10840192 10.1016/S0939-6411(00)00076-X 1:CAS:528:DC%2BD3cXjslyju7c%3D (Pubitemid 30326688)
6. DQM Craig 2002 The mechanism of drug release from solid dispersions in water-soluble polymers Int J Pharm 231 131 144 11755266 10.1016/S0378-5173(01) 00891-2 1:CAS:528:DC%2BD3MXptlaitL0%3D (Pubitemid 34033673)
7. T Kosoglou P Statkevich AO Johnson-Levonas JF Paolini AJ Bergman KB Alton 2005 EZE: a review of its metabolism, pharmacokinetics and drug interactions Clin Pharmacokinet 44 5 467 494 15871634 10.2165/00003088-200544050-00002 1:CAS:528:DC%2BD2MXlvVCrtbs%3D (Pubitemid 40733733)
8. LJ Lipka 2003 EZE: a first-in-class novel cholesterol absorption inhibitor Cardiovasc Drug Rev 21 4 293 312 14647533 10.1111/j.1527-3466.2003. tb00123.x 1:CAS:528:DC%2BD2cXnt1Kntw%3D%3D (Pubitemid 38029965)
9. RP Dixit MS Nagasenker 2008 Self-nanoemulsifying granules of EZE: design, optimization and evaluation Eur J Pharm Sci 35 183 192 18652892 10.1016/j.ejps.2008.06.013 1:CAS:528:DC%2BD1cXhtVyltrzJ
10. R Patel D Bhimani J Patel D Patel 2008 Solid-state characterization and dissolution properties of EZE-cyclodextrins inclusion complexes J Incl Phenom Macrocycl Chem 60 241 251 10.1007/s10847-007-9371-7 1:CAS:528: DC%2BD1cXktVCns70%3D
11. YV Pore PP Sancheti P Karekar VM Vyas M Shah 2009 Preparation and physicochemical characterization of surfactant based solid dispersions of EZE Pharmazie 64 4 227 231 19435139
12. G Van den Mooter P Augustijns N Blaton R Kinget 1998 Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30 Int J Pharm 164 67 80 10.1016/S0378-5173(97)00401-8 (Pubitemid 28160099)
13. M El-Badry M Fathy 2006 Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30 Drug Dev Ind Pharm 32 141 150 16537195 10.1080/03639040500465983 1:CAS:528:DC%2BD28XitFChurg%3D
14. VR Shinde MR Shelake SS Shetty AB Chavan-Patil VV Pore SG Late 2008 Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique J Pharm Pharmacol 60 1121 1129 18718114 10.1211/jpp.60.9.0002 1:CAS:528:DC%2BD1cXhtV2rtL3K
15. LP Ruan BY Yu GM Fu DN Zhu 2005 Improving the solubility of ampelopsin by solid dispersions and inclusion complexes J Pharm Biomed Anal 38 457 464 15925247 10.1016/j.jpba.2005.01.030 1:CAS:528:DC%2BD2MXltVegtbo%3D (Pubitemid 40733182)
16. N Ahuja OP Katare B Singh 2007 Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers Eur J Pharm Biopharm 65 26 38 16962750 10.1016/j.ejpb.2006.07.007 1:CAS:528:DC%2BD28Xht1KlsL7E (Pubitemid 44827692)
17. K Yamamoto S Chutimaworapan GC Ritthidej E Yonemochi T Oguchi 2000 Effect of water soluble carriers on dissolution characteristics of nifedipine solid dispersions Drug Dev Ind Pharm 26 11 1141 1150 11068687 10.1081/DDC-100100985
18. R Kalaiselvan GP Mohanta PK Manna R Manavalan 2006 Studies on mechanism of enhanced dissolution of albendazole solid dispersions with crystalline carriers Indian J Pharm Sci 68 5 599 607 10.4103/0250-474X.29627 1:CAS:528:DC%2BD2sXhtVKhurnM (Pubitemid 46087768)
19. T Higuchi KA Connors 1965 Phase solubility techniques Adv Anal Chem Instrum 4 117 212 1:CAS:528:DyaF2MXktlGitrg%3D
20. USFDA, Available at http://www.accessdata.fda.gov/scripts/cder/ dissolution/dsp-SearchResults-Dissolutions.cfm, Accessed on December 16, 2008.
21. RP Patel MM Patel 2007 Physicochemical characterization and dissolution study of solid dispersions of lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30 Pharm Dev Technol 12 21 33 17484141 10.1080/10837450601166510 1:CAS:528:DC%2BD2sXis1yqurw%3D (Pubitemid 46902607)
22. J Devane J Butler A Dunne T O'Hara 1998 A review of methods used to compare dissolution profile data Pharm Sci Technol Today 1 5 214 223 10.1016/S1461-5347(98)00053-4 (Pubitemid 28387122)
23. CM Fernandes MT Vieira JB Veiga 2002 Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds Eur J Pham Sci 15 79 88 10.1016/S0928-0987(01)00208-1 1:CAS:528: DC%2BD38Xms1Glsg%3D%3D (Pubitemid 34136971)
24. V Tantishaiyakul N Kaewnoparrat S Ingakatawornwong 1996 Properties of solid dispersions of piroxicam in polyvinypyrollidone-K30 Int J Pharm 143 59 66 10.1016/S0378-5173(96)04687-X 1:CAS:528:DyaK28Xnt1Wit78%3D (Pubitemid 26396399)
25. K Yamashita T Nakate K Okimoto A Ohike Y Tokunaga R Ibuki K Higaki T Kimura 2003 Establishment of new preparation method for solid dispersion formulation of tacrolimus Int J Pharm 267 79 91 14602386 10.1016/j.ijpharm.2003. 07.010 1:CAS:528:DC%2BD3sXosFOqtLw%3D (Pubitemid 37352952)
26. P Costa JMS Lobo 2001 Modeling and comparison of dissolution profiles Eur J Pharm Sci 13 123 133 11297896 10.1016/S0928-0987(01)00095-1 1:CAS:528:DC%2BD3MXisF2qs78%3D (Pubitemid 32288781)
27. W Ali AC Williams CF Rawlinson 2010 Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions Int J Pharm 391 162 168 20214957 10.1016/j.ijpharm.2010.03.014 1:CAS:528:DC%2BC3cXltFCnsL8%3D